Systems integration with DLSI

Systems integration aims to provide a homogenous view to a system consisting of many heterogeneous systems. Systems integration can be achieved by many means out of which the middleware approach is the most popular. This is because middleware can be built around existing systems thereby reducing the amount of changes needed for the integration. Nowadays many middleware technologies are available to integrate heterogeneous systems. One can chose among them depending upon the requirements. But due to the many technologies available for Middleware, a muddle of middleware exists. To reduce this muddle and to integrate the systems already implemented using different middleware technologies, Web Services plays a key role. Web Services is an XML-based technology which uses known protocols to communicate between applications, thus making them platform and technology independent. Digital Library Service Integration (DLSI) provides a systematic approach in integrating the digital library collections and services. Amazon\u27s website www.amazon.com is integrated with DLSI such that users see the same web pages as they see when they are logged in normally, but these pages will be augmented with link anchors. Wrappers will parse the web pages to look for elements of interests like book title, author name, etc., and provide them with link anchors which will connect the user to the library at New Jersey Institute of Technology where he or she can search for books or request them through interlibrary loan. The thesis proposes a new architecture for the DLSI as a web service, which can provide this functionality

International search behavior of Business Group affiliated firms: Scope of institutional changes and intragroup heterogeniety

This paper investigates whether and when affiliation to business groups enables or constrains firms’ international search behavior during institutional transitions. We theorize that given the unique structure and complex form of business group organizations, the search behavior of affiliated firms is influenced by the degree of (mis)alignment in outlook at the group and affiliate levels of management. We identify the scope of institutional changes, business group attributes, and affiliate characteristics as sources of such (mis)alignment. The results from panel data on 298 firms from the Indian pharmaceutical industry for the 1992–2007 period show that the constraining effects of business group affiliation are observed only when institutional changes are specific to the affiliates’ industry and not when broad institutional changes affect the business group as a whole. Moreover, we observe heterogeneity in the search behavior of group affiliated firms. First, the degree of misalignment is greater in the case of affiliates belonging to older business groups and those that are more distant in terms of age and industry since the group’s founding. Second, by contrast and suggesting an alignment in outlook, we find that affiliated firms that occupy a prominent position within a group or industry are able to bargain for and receive attention and support from the business group to undertake international search. Our findings have implications for research on the role of business groups in a changing institutional context and for the strategic adaptation of firms embedded in complex organizational and institutional settings

Prognostic factors for chronic post-surgical pain after lung or pleural surgery: A protocol for a systematic review and meta-analysis

INTRODUCTION: Chronic post-surgical pain (CPSP) after lung or pleural surgery is a common complication and associated with a decrease in quality of life, long-term use of pain medication and substantial economic costs. An abundant number of primary prognostic factor studies are published each year, but findings are often inconsistent, methods heterogeneous and the methodological quality questionable. Systematic reviews and meta-analyses are therefore needed to summarise the evidence. METHODS AND ANALYSIS: The reporting of this protocol adheres to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) checklist. We will include retrospective and prospective studies with a follow-up of at least 3 months reporting patient-related factors and surgery-related factors for any adult population. Randomised controlled trials will be included if they report on prognostic factors for CPSP after lung or pleural surgery. We will exclude case series, case reports, literature reviews, studies that do not report results for lung or pleural surgery separately and studies that modified the treatment or prognostic factor based on pain during the observation period. MEDLINE, Scopus, Web of Science, Embase, Cochrane, CINAHL, Google Scholar and relevant literature reviews will be searched. Independent pairs of two reviewers will assess studies in two stages based on the PICOTS criteria. We will use the Quality in Prognostic Studies tool for the quality assessment and the CHARMS-PF checklist for the data extraction of the included studies. The analyses will all be conducted separately for each identified prognostic factor. We will analyse adjusted and unadjusted estimated measures separately. When possible, evidence will be summarised with a meta-analysis and otherwise narratively. We will quantify heterogeneity by calculating the Q and I ETHICS AND DISSEMINATION: Ethical approval will not be necessary, as all data are already in the public domain. Results will be published in a peer-reviewed scientific journal. PROSPERO REGISTRATION NUMBER: CRD42021227888

Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon

<p>Abstract</p> <p>Background</p> <p>MLL2, an epigenetic regulator in mammalian cells, mediates histone 3 lysine 4 tri-methylation (H3K4me3) through the formation of a multiprotein complex. MLL2 shares a high degree of structural similarity with MLL, which is frequently disrupted in leukemias via chromosomal translocations. However, this structural similarity is not accompanied by functional equivalence. In light of this difference, and previous reports on involvement of epigenetic regulators in malignancies, we investigated MLL2 expression in established cell lines from breast and colon tissues. We then investigated MLL2 in solid tumors of breast and colon by immunohistochemistry, and evaluated potential associations with established clinicopathologic variables.</p> <p>Results</p> <p>We examined MLL2 at both transcript and protein levels in established cell lines from breast and colon cancers. Examination of these cell lines showed elevated levels of MLL2. Furthermore, we also identified incomplete proteolytic cleavage of MLL2 in the highly invasive tumor cell lines. To corroborate these results, we studied tumor tissues from patients by immunohistochemistry. Patient samples also revealed increased levels of MLL2 protein in invasive carcinomas of the breast and colon. In breast, cytoplasmic MLL2 was significantly increased in tumor tissues compared to adjacent benign epithelium (p < 0.05), and in colon, both nuclear and cytoplasmic immunostaining was significantly increased in tumor tissues compared to adjacent benign mucosa (p < 0.05).</p> <p>Conclusion</p> <p>Our study indicates that elevated levels of MLL2 in the breast and colon cells are associated with malignancy in these tissues, in contrast to MLL involvement in haematopoietic cancer. In addition, both abnormal cellular localization of MLL2 and incomplete proteolytic processing may be associated with tumor growth/progression in breast and colonic tissues. This involvement of MLL2 in malignancy may be another example of the role of epigenetic regulators in cancer.</p

Assessing the Effectiveness of Chemical Marker Extraction from Amazonian Plant Cupuassu (Theobroma grandiflorum) by PSI-HRMS/MS and LC-HRMS/MS.

Acknowledgments The authors acknowledge the institutional and financial support from the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES) and the Brazilian Research Council (CNPq). Funding This research received no external funding.Peer reviewedPublisher PD

Mass spectrometry-based untargeted metabolomics approaches for comprehensive structural annotation of bioactive metabolites from bushy cashew (Anacardium humile) fruits

Funding Information: The authors acknowledge financial support from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for the institutional and financial support. Publisher Copyright: © 2023Peer reviewedPostprin

Regulation of HuR structure and function by dihydrotanshinone-I

The Human antigen R protein (HuR) is an RNA-binding protein that recognizes U/AU-rich elements in diverse RNAs through two RNA-recognition motifs, RRM1 and RRM2, and post-transcriptionally regulates the fate of target RNAs. The natural product dihydrotanshinone-I (DHTS) prevents the association of HuR and target RNAs in vitro and in cultured cells by interfering with the binding of HuR to RNA. Here, we report the structural determinants of the interaction between DHTS and HuR and the impact of DHTS on HuR binding to target mRNAs transcriptome-wide. NMR titration and Molecular Dynamics simulation identified the residues within RRM1 and RRM2 responsible for the interaction between DHTS and HuR. RNA Electromobility Shifts and Alpha Screen Assays showed that DHTS interacts with HuR through the same binding regions as target RNAs, stabilizing HuR in a locked conformation that hampers RNA binding competitively. HuR ribonucleoprotein immunoprecipitation followed by microarray (RIP-chip) analysis showed that DHTS treatment of HeLa cells paradoxically enriched HuR binding to mRNAs with longer 3'UTR and with higher density of U/AU-rich elements, suggesting that DHTS inhibits the association of HuR to weaker target mRNAs. In vivo, DHTS potently inhibited xenograft tumor growth in a HuR-dependent model without systemic toxicity